呲仑帕奈纳入医保了吗？

Eisai (China) Pharmaceutical Co., Ltd. successfully held the China launch conference of Vecta(R) on December 3, 2019, marking the official launch of the new third-generation anti-epileptic drug Vecta® in China. This means that China’s epilepsy treatment field has officially welcomed the first non-competitive AMPA receptor antagonist, which will bring new treatment methods and means to the majority of epilepsy patients and their families.

Recently, a multicenter UK observational study of 96 children and adolescents with refractory epilepsy who received garampanel showed an overall response rate of 18.8% across all epilepsy types at 6 and 12 months of follow-up. There are also some studies that have observed the efficacy of parampanel in some epilepsy syndromes. Studies have found that parampanel is very effective in patients with Dravet syndrome. 4/5 patients achieved clinical improvement, and two patients did not even develop epilepsy.

Is Perampanel included in medical insurance? The launch of Perampanel in China has undoubtedly brought great good news to domestic patients, making their diseases treatable and curable. In particular, this drug is also a national medical insurance drug. Due to different medical insurance reimbursement policies in different places, patients are advised to go to the local medical insurance bureau to inquire about the specific price and reimbursement ratio. But even after medical insurance, the price of parampanel is still beyond the reach of most patients. At this time, most patients choose to turn to domestic and overseas medical service organizations Medical Companion Travel to help them purchase parampanel. This is because the version of Parampanel purchased by Medical Companion Travel is more affordable than the domestic version with medical insurance and is more suitable for patients to use for a long time. Moreover, Medical Companion Travel is a convenient and safe way to purchase drugs, making it the best choice for domestic patients to purchase drugs overseas.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.